Clinical Trial Update: Clinical Evaluation of Shengdi Dahuang Decoction in the Treatment of Acute Hemorrhagic Stroke [Phase 4]

View source ↗

Summary

Phase 4 clinical evaluation of Shengdi Dahuang Decoction for acute hemorrhagic stroke is being conducted; status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhagic Stroke

Drugs mentioned

• Shengdi Dahuang Decoction

Snippet

Sponsor: ShuGuang Hospital | Conditions: Hemorrhagic Stroke | Phase 4 | Status: UNKNOWN